Key result
Prompt recognition and supportive care resolve potentially lethal serotonin syndrome triggered by serotonergic agents.
Serotonin syndrome is a potentially lethal adverse drug reaction that requires prompt recognition and supportive care in clinical practice.
Prompt recognition of serotonin syndrome remains essential to avert lethality; leaves open prospective studies on prevention in polypharmacy.
Serotonin Syndrome (SS) is a rare, but lethal, adverse drug reaction caused by excessive serotonin activity in the nervous system. Serotonin syndrome is more accurately described as serotonin toxicity and can be triggered by serotonergic agents either alone or in combination with monoamine oxidase inhibitors (MAOIs). It may occur after one standard therapeutic dose of a single agent, unintentional interactions between various medications, drug overdose, as well as recreational drug use. Symptoms present as alteration of mental status, abnormalities of neuromuscular tone, and autonomic hyperactivity. Although effects are usually mild and resolve with prompt recognition and supportive care, there exists a strong need for integration of these preventative measures in current clinical practice.
No takes yet. Share an insight, caveat, or question.
Mohammad Iqbal (2015) conducted a review in Serotonin Syndrome. Serotonergic agents was evaluated. Serotonin syndrome is a potentially lethal adverse drug reaction triggered by serotonergic agents that requires prompt recognition and supportive care for resolution.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: